More about Centene Corporation
Regulatory Filings for Centene Corporation
Fundamentals for Centene Corporation
Debt, Deficits & Disaster: The Bond Market Crisis
Not Wall Street, But AI: The Real Force Democratizing Finance Across America
When Flooding Pays: A New Financial Bet
Breakfast for Life How Local Diners and Hardware Stores are Outsmarting Amazon
Fundamentals for Centene Corporation
Business Operations:
Sector: HealthcareIndustry: Healthcare Plans
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
Revenue projections:
Centene Corporation is projected to see lower revenues than in the previous year, a trend that usually concerns investors. Declining revenues often harm a company's profitability, leading investors to exercise caution as they weigh the potential risks of continued financial downturns.
Financial Ratios:
| currentRatio | 1.123000 |
|---|---|
| forwardPE | 12.511184 |
| debtToEquity | 76.049000 |
| earningsGrowth | 0.186000 |
| revenueGrowth | 0.155000 |
| grossMargins | 0.111290 |
| operatingMargins | 0.037260 |
| trailingEps | -13.050000 |
| forwardEps | 4.314540 |
Centene Corporation's current ratio, being 1.123, demonstrates that the company has the liquidity necessary to service its short-term debt. With strong cash reserves and current assets, Centene Corporation is well-equipped to meet its immediate financial obligations without any difficulties.
Centene Corporation's Forward PE ratio is in a good range, reflecting a reasonable balance between stock price and earnings. The stock is not overpriced, leaving room for growth, which suggests potential for investors looking to capitalize on future value appreciation.
CNC's positive earnings and revenue growth signal the company's business is on track for further expansion. These strong financial trends suggest that CNC will continue to grow its operations, driven by increasing profits and revenue.
Price projections:
The price of CNC has consistently been close to the lower limit of expectations. This trend may point to challenges in the company's performance, leading to concerns about its future growth potential.
Insider Transactions:
There were 1 CNC sales transactions, at market price of 38.849998474121094.There were 2 buy transactions of Centene Corporation, with market price at 26.225000381469727.The insider transaction data shows no clear pattern or trend, making it difficult to draw any meaningful conclusions about the company's current direction based on this information.
Recommendation changes over time:
CNC has been receiving a buy bias from analysts, signaling strong confidence in the stock's future performance. This positive outlook might drive investors to view CNC as an attractive option for their portfolios, positioning the company as a stable and profitable investment choice.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst technicals.
Latest Regulatory Filings for SP5
Companies with the best and the worst fundamentals.
Before They Can Walk, They're Invested: How Trump Accounts Are Transforming Financial Culture
The Appalachian Energy Reboot: Inside the Unexpected Nuclear Startup Boom
Theatrical Finance: Credit Unions Use Drama to Attract Youth